Cointime update: US Senator Ron Wyden said he will keep close watch on large pharmaceutical companies and insurance firms, signaling congressional scrutiny of the two industries. The statement from the senator did not specify which companies or what oversight actions might follow. It comes as lawmakers continue to focus on drug pricing and health insurance practices.
Senator Wyden Says He Will Scrutinize Large Drugmakers and Insurers
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
1h ago
CoinShares Q3 AUM Rebounds to $7.4B, Turns Profit; Board Approves Up to $40M Buyback
1h ago
Bitwise Files S-1 for Spot Zcash ETF on Texas Stock Exchange
1h ago
House Democrats Target Trump Inner Circle in First Oversight Requests
2h ago
US Democrats Plan Data Center Power Reform, Operators May Pay $35B More Over 10 Years
3h ago
Goldman Sachs’ Ethereum ETF Holdings Rise to $1.22B in Q3, ETHA Stake Up 352%
3h ago
Charles Schwab Adds 749,566 Strive Shares Worth $77.2M